


Healthcare Industry News: adalimumab)
News Release - May 21, 2008
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Source: Abbott
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
